New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
15:03 EDTFRX, ARRYArray BioPharma hires new Chief Scientific Officer, VP of R&D
Array BioPharma (ARRY) announced the appointments of Nicholas Saccomano, Ph.D., as Chief Scientific Officer and Robert Winkler, M.D., as VP of Clinical Research and Development. Saccomano most recently served as Chief Technology Officer at SomaLogic and as Chief Scientific Officer at Bend Research. Winkler most recently served as VP of Global Clinical Development and Operations at Aptalis Pharma, which was recently acquired by Forest Labs (FRX).
News For ARRY;FRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 1, 2015
10:11 EDTARRYHigh option volume stocks
Subscribe for More Information
September 28, 2015
12:25 EDTARRYArray data have positive read-through to Phase 3 trial, says Piper Jaffray
Subscribe for More Information
12:22 EDTARRYArray says binimetinib-encorafenib combo shows differentiated tolerability
Subscribe for More Information
September 25, 2015
08:39 EDTARRYArray BioPharma to host conference call
Conference call to discuss preliminary results from two melanoma trials and a colorectal cancer trial will be held on September 28 at 9 am. Webcast Link
September 24, 2015
10:25 EDTARRYOptions with decreasing implied volatility
Options with decreasing implied volatility: HRTX ATML ARRY YY OVTI RHT KMX

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use